Aldocumar: UK Status and Risks
Aldocumar does not have MHRA approval as a medicine in the UK. It may still appear in some catalogs, but no MHRA review of its safety or effectiveness covers it.
Check with a pharmacist before relying on it, and verify a seller's registration before buying. A seller who is vague about licensing status is worth a direct question to the seller.
Not UK-licensed. This medicine is not supplied through UK-registered pharmacies.
Sellers list the active ingredient as acenocoumarol. The MHRA has not assessed what these products actually contain.
The MHRA warns that medicines sold outside registered pharmacies can be counterfeit, contaminated, or contain the wrong amount of active ingredient. Buy prescription-only medicines from a pharmacy registered in the UK.
Pharmacies by area for Aldocumar (UK-licensed equivalent)
- North East · 884 pharmacies
- North West · 2538 pharmacies
- Yorkshire and The Humber · 1676 pharmacies
- East Midlands · 1307 pharmacies
- West Midlands · 1778 pharmacies
- East of England · 1860 pharmacies
- London · 3261 pharmacies
- South East · 2368 pharmacies
- South West · 1374 pharmacies
- Northern Ireland · 714 pharmacies
- Scotland · 1725 pharmacies
- Wales · 1050 pharmacies
Pharmacies near you
Use your location to open the pharmacies closest to you and ask them about Aldocumar, the UK-licensed medicine with the same active ingredient.
Cities with the most pharmacies
- London · 724 pharmacies
- Birmingham · 265 pharmacies
- Nottingham · 180 pharmacies
- Glasgow · 177 pharmacies
- Leeds · 173 pharmacies
- Sheffield · 162 pharmacies
- Bristol · 148 pharmacies
- City of London · 144 pharmacies
- Manchester · 134 pharmacies
- Edinburgh · 131 pharmacies
- Bolton · 124 pharmacies
- Belfast · 122 pharmacies
- Hampstead · 121 pharmacies
- Coventry · 115 pharmacies
- Cardiff · 112 pharmacies
About Aldocumar
Aldocumar is not a licensed medicine in the United Kingdom and cannot legally be sold there as a medicine. The product information does not identify an active ingredient, pharmaceutical class, dosage form, strength, or established medical use.
This makes its contents, quality, safety, and suitability difficult to assess. Advice from a doctor or pharmacist is appropriate before considering any unlicensed product.
Claimed strengths are manufacturer claims, but no strength is listed for Aldocumar. No dosage schedule, quantity, or administration instructions are stated.
The absence of a listed strength means that a safe dose cannot be assessed from the product details. Aldocumar should not be treated as having the dosing characteristics of a licensed medicine.
What Aldocumar is used for
Aldocumar has no clearly identified active ingredient or stated pharmaceutical class. Consequently, no specific marketed treatment claim can be described responsibly. Advertisements may present uses for a product, but those claims are not established medical facts here.
The product should not be relied upon to diagnose, prevent, manage, or treat a health condition. A doctor or pharmacist can discuss symptoms and suitable licensed options instead.
How Aldocumar works
A reliable explanation of how it works is therefore not possible. Medicines normally produce effects through a known active substance acting on particular receptors, enzymes, transport systems, or other biological pathways.
Without knowing the substance and amount, those effects, possible benefits, adverse effects, and interactions cannot be predicted. A registered United Kingdom pharmacy or a doctor may help assess an alternative with clearly stated ingredients and regulatory status.
Main interactions
- Interactions cannot be assessed because no active ingredient is identified.
- Unknown ingredients may interact with prescribed medicines, pharmacy medicines, or supplements.
- Extra caution is appropriate with medicines affecting bleeding, blood pressure, heart rhythm, alertness, or blood glucose when ingredients are uncertain.
- A doctor or pharmacist should check the complete ingredient list before combining this product with any medicine.
- Alcohol and other substances may add to unwanted effects when the product contents are unclear.
Key warnings
- Aldocumar is not a licensed medicine in the United Kingdom and cannot legally be sold there as a medicine.
- The product has not been independently verified for identity, strength, quality, or purity.
- The active ingredient and pharmaceutical class are not identified, so safety risks cannot be assessed reliably.
- No dosage form or strength is listed, making dose-related harm difficult to predict.
- Unclear ingredients may create a risk of allergy, toxicity, or an unexpected pharmacological effect.
- Seek advice from a doctor or pharmacist before considering an unlicensed product.
Pregnancy and breastfeeding
The marketing material does not specify pregnancy or lactation data for Aldocumar. Because the active ingredient and strength are not identified, safety during pregnancy or breastfeeding cannot be assessed.
Discuss any planned or current use with a doctor or pharmacist before exposure. Do not substitute this product for a prescribed treatment.
Missed dose
A missed-dose recommendation cannot be given because Aldocumar has no identified active ingredient, strength, or dosing schedule. Doubling a later dose can be unsafe when the contents and intended regimen are uncertain.
A doctor or pharmacist can advise after checking the product and any accompanying instructions. Urgent help is appropriate if an excessive amount may have been used or unexpected symptoms develop.
Storage
No storage conditions are listed for Aldocumar. Keep the product in its original packaging, away from children, excessive heat, moisture, and direct sunlight, and follow any storage wording on the packaging. A pharmacist can advise whether the product should be retained or discarded if its condition or contents are uncertain.
Related medicines
First published October 2, 2026 · Last updated · Report an error on this page